The use of antibody specific for bromodeoxyuridine for the immunofluorescent determination of DNA replication in single cells and chromosomes☆
References (17)
- et al.
- et al.
Biophys j
(1963) - et al.
Exp cell res
(1959) - et al.
Exp cell res
(1973) - et al.
Biochim biophys acta
(1974) - et al.
Exp cell res
(1972) - et al.
Exp cell res
(1974) Exp cell res
(1974)
Cited by (127)
Recent advances in nucleotide analogue-based techniques for tracking dividing stem cells: An overview
2021, Journal of Biological ChemistryCitation Excerpt :The major disadvantages of 3H-thymidine are handling of a radioactive substance and the use of the time-consuming autoradiography method for detection. Detection of 5-bromo-2′-deoxyuridine (BrdU) (Table 1), a synthetic nucleoside analogue of thymidine, is an alternative technique for the determination of DNA replication and has overcome these disadvantages (12, 13). BrdU incorporated into DNA is recognized by a specific polyclonal or monoclonal antibody produced against bromouridine or iododeoxyuridine complexed to a carrier protein such as bovine serum albumin.
5-Ethynyl-2-deoxycytidine and 5-ethynyl-2-deoxyuridine are differentially incorporated in cells infected with hsv-1, hcmv, and kshv viruses
2020, Journal of Biological ChemistryPostsynthetic Modifications of DNA and RNA by Means of Copper-Free Cycloadditions as Bioorthogonal Reactions
2020, Bioconjugate ChemistryPeptidoglycan accelerates granulopoiesis through a TLR2- and MyD88-dependent pathway
2017, Biochemical and Biophysical Research CommunicationsIsolating dividing neural and brain tumour cells for gene expression profiling
2016, Journal of Neuroscience MethodsCitation Excerpt :Thymidine analogues are the method of choice for labelling dividing cells in anatomical studies (Cavanagh et al., 2011; Chehrehasa et al., 2009; Gratzner et al., 1975; Salic and Mitchison, 2008).
Development of ethynyl-2′-deoxyuridine chemical probes for cell proliferation
2016, Bioorganic and Medicinal Chemistry
- ☆
This work was supported by NCI Contract, NO1-CB-43962 and NO1-CB-33861, and by General Research Support Grant, NIH-5501-RR-05690-03, NIH Grant, CA13441 and by grant 884M from the Council of Tobacco Research-USA Inc.